The relationship between CD204 M2-polarized tumour-associated macrophages (TAMs), tumour-infiltrating lymphocytes (TILs), and microglial activation in glioblastoma microenvironment: a novel immune checkpoint receptor target

Springer Science and Business Media LLC - 2021
Maher Kurdi1, Badrah S. Alghamdi2, Nadeem Shafique Butt3, Saleh Baeesa4
1Department of Pathology, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia
2Department of Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
3Department of Family and Community Medicine, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia
4Division of Neurosurgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Tóm tắt

Abstract Background Tumour associated macrophages (TAMs) and tumour infiltrating lymphocytes (TILs) are considered dominant cells in glioblastoma microenvironment. Aim The purpose of this study was to assess the expression of CD204+ M2-polarized TAMs in glioblastomas and their relationship with CD4+TILs, Iba+microglia, and IDH1 mutation. We also exploreed the prognostic value of these markers on the recurrence-free interval (RFI). Methods The expressions of CD204+TAMs, CD4+TILs, and Iba1+microglia were quantitively assessed in 45 glioblastomas using immunohistochemistry. Kaplan–Meier analysis and Cox hazards were used to examine the relationship between these factors. Results CD204+TAMs were highly expressed in 32 tumours (71%) and the remaining 13 tumours (29%) had reduced expression. CD4+TILs were highly expressed in 10 cases (22%) and 35 cases (77.8%) had low expression. There was an inverse correlation between CD204+TAMs and CD4+TILs, in which 85% of tumours had a high expression of CD204+TAMs and a low expression of CD4+TILs. Nevertheless, there was no significant difference in IDH1 mutation status between the two groups (p = 0.779). There was a significant difference in Iba1+microglial activation between IDH1mutant and IDH1wildtype groups (p = 0.031). For cases with a high expression of CD204+TAMs and a low expression of CD4+TILs, there was a significant difference in RFI after treatment with chemoradiotherapy or radiotherapy (p = 0.030). Conclusion Glioblastoma with a dense CD204+TAMs and few CD4+TILs is associated with IDH1wildtype. These findings suggest that TAMs masks tumour cell and suppress T-cell tumoricidal functions via immunomodulatory mechanisms. Blockade of the CD204-TAM receptor may prevent this mechanism and allow the evolution of TILs.

Từ khóa


Tài liệu tham khảo

Brennan C, Verhaak R, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155:462–77. https://doi.org/10.1016/j.cell.2013.09.034.

Chen Z, Hambardzumyan D. Immune microenvironment in glioblastoma subtypes. Front Immunol. 2018;9:1004. https://doi.org/10.3389/fimmu.2018.01004.

Corrales L, Matson V, Flood B, Spranger S, Gajewski TF. Innate immune signaling and regulation in cancer immunotherapy. Cell Res. 2017;27:96–108. https://doi.org/10.1038/cr.2016.149.

Feng X, Szulzewasky F, Yerevanian A, Chen Z, et al. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Oncotarget. 2015;6:15077–94. https://doi.org/10.18632/oncotarget.3730.

Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717–34. https://doi.org/10.1038/nrclinonc.2017.101.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–4. https://doi.org/10.1126/science.1129139.

Garber ST, Hashimoto Y, Weather SP, Xiu J, Gatalica Z, et al. Immune check point blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016;18:1357–66. https://doi.org/10.1093/neuonc/now132.

Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B. Immune microenvironment of gliomas. Lab Invest. 2017;97:498–518. https://doi.org/10.1038/labinvest.2017.19.

Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69:2000–9. https://doi.org/10.1158/0008-5472.CAN-08-2360.

Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in brain tumors. Glia. 2002;40:252–9. https://doi.org/10.1002/glia.10147.

Gutmann DH, Kettenmann H. Microglia/brain macrophages as central drivers of brain tumor pathobiology. Neuron. 2019;104:442–9. https://doi.org/10.1016/j.neuron.2019.08.028.

Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends Cancer. 2015;1:252–65. https://doi.org/10.1016/j.trecan.2015.10.009.

Han S, Zhang C, Li Q, Fong J, et al. Tumour-infiltrating CD4. and CD8. lymphocytes as predictors of clinical outcome in glioma. Br J Cancer. 2014;110:2560–8. https://doi.org/10.1038/bjc.2014.162.

Heiland DH, Haaker G, Delev D, Mercas B. Comprehensive analysis of PD-L1 expression in glioblastoma multiform. Oncotarget. 2017;8:91779–94. https://doi.org/10.18632/oncotarget.15031.

Ho WY, Yee C, Greenberg PD. Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends. J Clin Invest. 2002;110:1415–7. https://doi.org/10.1172/JCI17214.

Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol. 2006;8:261–79. https://doi.org/10.1215/15228517-2006-008.

Ichimura T, Morikawa T, Kawai T, et al. Prognostic significance of CD204-positive macrophages in upper urinary tract cancer. Ann Surg Oncol. 2014;21:2105–12. https://doi.org/10.1245/s10434-014-3503-2.

Kurahara H, Shinchi H, Mataki Y, et al. Significance of M2- polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011;167:e211–9. https://doi.org/10.1016/j.jss.2009.05.026.

Li G, Wang Z, Zhang C, Liu X, Cai J, et al. Molecular and clinical characterization of TIM-3 in glioma through 1.204 samples. Oncoimmunology. 2017;6:e1328339. https://doi.org/10.1080/2162402X.2017.1328339.

Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. https://doi.org/10.1007/s00401-007-0243-4.

Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, et al. Tumor-infiltrating CD8. lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011;29:1949–55. https://doi.org/10.1200/JCO.2010.30.5037.

Murray P, Allen J, Biswas S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14–20. https://doi.org/10.1016/j.immuni.2014.06.008.

Ohtaki Y, Ishii G, Nagai K, et al. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. J Thorac Oncol. 2010;5:1507–15. https://doi.org/10.1097/JTO.0b013e3181eba692.

Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell. 2017;31:326–41. https://doi.org/10.1016/j.ccell.2017.02.009.

Reardon DA, Gokhale PC, Klein SR, et al. Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model. Cancer Immunol Res. 2016;4:124–35. https://doi.org/10.1158/2326-6066.CIR-15-0151.

Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiledcoil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 1990;343:570–2. https://doi.org/10.1038/343570a0.

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, et al. Intraepithelial CD8 tumor-infiltrating lymphocytes and a high CD8/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:18538–43. https://doi.org/10.1073/pnas.0509182102.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96. https://doi.org/10.1056/NEJMoa043330.

Ye XZ, Xu SL, Xin YH, et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGFbeta1 signaling pathway. J Immunol. 2012;189:444–53. https://doi.org/10.4049/jimmunol.1103248.

Yuan Y, Zhao Q, Zhao S, Zhang P, Zhao H, et al. Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma. Cancer Med. 2019;8:3811–2. https://doi.org/10.1002/cam4.2312.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả